2005
DOI: 10.1158/1541-7786.mcr-05-0233
|View full text |Cite
|
Sign up to set email alerts
|

The Emerging Role of the COP9 Signalosome in Cancer

Abstract: In the last several years, multiple lines of evidence have suggested that the COP9 signalosome (CSN) plays a significant role in the regulation of multiple cancers and could be an attractive target for therapeutic intervention. First, the CSN plays a key role in the regulation of Cullin-containing ubiquitin E3 ligases that are central mediators of a variety of cellular functions essential during cancer progression. Second, several studies suggest that the individual subunits of the CSN, particularly CSN5, migh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
88
0
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(90 citation statements)
references
References 110 publications
1
88
0
1
Order By: Relevance
“…As for PIF3, the light-specific phosphorylation forms of PIF4 and PIF5 appear to be the shortest-lived ones (Figures 4 and 6). Regulation of proteasome-mediated degradation of transcription factors is not uncommon (AlSady et al, 2006;Collins and Tansey, 2006;Hardtke et al, 2000;Richardson and Zundel, 2005). In mammalian systems, activation and degradation of transcription factors are often coupled, presumably to ensure tight control of the activation mechanism (Collins and Tansey, 2006).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As for PIF3, the light-specific phosphorylation forms of PIF4 and PIF5 appear to be the shortest-lived ones (Figures 4 and 6). Regulation of proteasome-mediated degradation of transcription factors is not uncommon (AlSady et al, 2006;Collins and Tansey, 2006;Hardtke et al, 2000;Richardson and Zundel, 2005). In mammalian systems, activation and degradation of transcription factors are often coupled, presumably to ensure tight control of the activation mechanism (Collins and Tansey, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, in response to a light treatment, additional more slowly-migrating forms appear very transiently (Figures 4-6, and Supplementary Figures S2 and S3). As proteasomemediated degradation is often regulated by specific phosphorylation events (Al-Sady et al, 2006;Collins and Tansey, 2006;Hardtke et al, 2000;Richardson and Zundel, 2005), we tested whether PIF4 and PIF5 are phosphoproteins. Extracts of dark-grown and etiolated seedlings exposed for 1 h to R Figure 6.…”
Section: Pif5 Protein Accumulation Is Controlled By R/fr Ratiomentioning
confidence: 99%
“…Taken together, our data suggest that Rig-G may work as a negative regulator of JAB1 function. Over the last several years, JAB1 also has been known as COP9 signalosome subunit 5 (CSN5), which is a component of the COP9 signalosome regulatory complex (26)(27)(28). Some reports show that JAB1͞CSN5 subunit possesses a metalloprotease catalytic activity that is required for the COP9 holocomplexdirected deneddylation of the Cullins, a subunit of SCF (Skp1-Cullin-F-box protein) ubiquitin E3 ligases (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…Some reports show that JAB1͞CSN5 subunit possesses a metalloprotease catalytic activity that is required for the COP9 holocomplexdirected deneddylation of the Cullins, a subunit of SCF (Skp1-Cullin-F-box protein) ubiquitin E3 ligases (29,30). Although JAB1͞CSN5 can exist in a monomeric form and act independently of COP9 holocomplex (7,28), it should be interesting to explore in the future whether Rig-G has effects on the function of COP9 holocomplex through interaction with JAB1͞CSN5.…”
Section: Discussionmentioning
confidence: 99%
“…This both terminates E3 activity and is required for the reassembly of new CRLs (Wei et al, 2008). The CSN plays a role in many cancer-associated pathways including the cell cycle and DNA damage repair, and both CSN and CRL components may be dysregulated in tumours (Richardson and Zundel, 2005). Ubp12p, an S. pombe ortholog of human USP15, was shown through a systematic mass spectrometry screen to bind the CSN (Zhou et al, 2003).…”
Section: Functionmentioning
confidence: 99%